Support our discoveries in child health

With the end of the year fast approaching, we invite you to support our research discoveries to help bring us one step closer to a world where every child has the opportunity to live a healthy and fulfilled life.

Donate today


Why donate to Murdoch Children’s Research Institute?  

  • We are one of the top three child health research institutes worldwide for research quality and impact*.
  • 1,600 researchers working across more than 150 diseases.
  • 1,800 research partners and 14,000 collaborations across 143 countries.
  • Close collaboration across the Melbourne Children's Campus with The Royal Children's Hospital and the University of Melbourne.
  • For the many diseases and health conditions affecting children, the earlier they are diagnosed, the sooner they can be prevented or treated.
  • We ensure our discoveries are transformed into better health outcomes for all children and their families around the world.

* 'Murdoch Children’s Performance analysis and benchmarking report' (Clarivate, August 2020).

Meet Professor Ravi Savarirayan and Cruze.

Professor Ravi Savarirayan is a clinical geneticist and leader of the MCRI Molecular Therapies research group who delivers ground-breaking clinical trials for children impacted by skeletal conditions, including achondroplasia.

Recent discoveries in genetic technologies have allowed Professor Savarirayan and his team to better understand bone conditions like achondroplasia and how to best treat them. 

We are so grateful for supporters like yourself who help make discoveries possible.

Thank you for your support. 

Professor Ravi Savarirayan is a clinical geneticist and leader of the MCRI Molecular Therapies research group who delivers ground-breaking clinical trials for children impacted by skeletal conditions, including achondroplasia.

Recent discoveries in...

Professor Ravi Savarirayan is a clinical geneticist and leader of the MCRI Molecular Therapies research group who delivers ground-breaking clinical trials for children impacted by skeletal conditions, including achondroplasia.

Recent discoveries in genetic technologies have allowed Professor Savarirayan and his team to better understand bone conditions like achondroplasia and how to best treat them. 

We are so grateful for supporters like yourself who help make discoveries possible.

Thank you for your support.